Onyx Pharmaceuticals Inc. (ONXX) is in the Pharma Industry

• Sort by
• View by Content Type
• View Related Content by Tag

• Onyx's $320M Bet on BTG's Anticancer Compound

  Eben Tessari submits: BTG has granted the worldwide commercialization and development rights of BGC 945, a novel anticancer compound, to Onyx ONXX in exchange for a potential $320M. BGC 945 is a novel compound that inhibits thymidylate synthase (TS), an enzyme involved in cell growth and division. However,...

  External links 2008-11-10

  Tags: Compound, Onyx Software, Cell, Seeking Alpha, Eben Tessari, BGC 945, Onyx Pharmaceuticals Inc., Healthcare

• ONYX Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript

  Question-and-Answer SessionThank you. [Operator Instructions]. Our first question comes from Jim Birchenough from Barclays Capital. Please go ahead. James Birchenough - Barclays Capital Yes. Hi guys. Hey, so a couple of questions. One just talking about the guidance you just provided as I wanted the map you are really...

  Earnings calls 2008-11-07

  Tags: Guidance, Barclays Plc., Call Transcript, Earnings, Onyx Pharmaceuticals Inc., Greg, Corporate Governance, Free Trade, Business Operations, Corporate Law, Finance, Seeking Alpha

• Zacks Analyst Blog Highlights: Schlumberger Ltd., Amylin Pharmaceuticals, Inc., Eli Lilly & Co., Onyx Pharmaceuticals, Inc. and Diageo Plc

  CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Schlumberger Ltd. (NYSE: SLB), Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly...

  Research articles 2008-10-23

  Tags: Amylin Pharmaceuticals Inc., blog, Diageo Plc., Eli Lilly & Co., FINANCE, Investment, Lilly, MARKETING, Nasdaq Stock Market Inc., New York Stock Exchange, newsletter, Onyx Pharmaceuticals Inc., Schlumberger Ltd., stock

• 5 Potential Buyout Targets in Biotech - Barron's

  Bristol-Myers Squibb BMY made a $4.5B bid for the shares of ImClone IMCL it doesn't already own. Roche Holdings (RHHBY.PK) made a $44B offer for the shares of Genetech DNA it doesn't own. Both targets want the bid prices raised. Barron's Lawrence Strauss says these are just the two latest...

  External links 2008-08-17

  Tags: Biotech, Alexion Pharmaceuticals Inc., Amylin Pharmaceuticals Inc., Bristol-Myers Squibb Co., Genentech Inc., ImClone Systems Inc., Eli Lilly & Co., Merck & Co. Inc., Onyx Pharmaceuticals Inc., Pfizer Inc., United Therapeutics Corp., Vertex Pharmaceuticals Inc., Wyeth

• 41 Stocks Returning 10% or More Last Week

  Trader Mark submits: This week's list of top performers has high exposure to retail and solar; areas we have been moving into the past few weeks with greater weightings.... but more into solar than retail for the fund. This list continues to show us that "beaten down" merchandise from the...

  External links 2008-08-17

  Tags: US Market, AIXTRON AG, Alaska Air Group Inc., Ameristar Casinos Inc., Clearwire Corp., Cree, Ctrip Com International Ltd., Cablevision Systems Corp., Cypress Semiconductor Corp., Estee Lauder Cos. Inc., Elan Corp. Plc., Energy Conversion Devices Inc., Enersys, Emeritus Corp., Fossil Inc., Geo Group Inc., General Motors Corp., Genco Shipping & Trading Ltd., Hansen Natural Corp., Hearst-Argyle Television Inc., International Rectifier Corp., J.C. Penney Co. Inc., Kohl's Corp., Longs Drug Stores Corp., Lennox International Inc., Las Vegas Sands Corp., MBIA Inc., NRG Energy Inc., NetEase Inc., NVidia Corp., Onyx Pharmaceuticals Inc., Open Text Corp., Pioneer Drilling Co., Penn National Gaming Inc., Petroleum Development Corp., Starbucks Corp., SunPower Corp., Seagate Technology LLC, Tenneco Inc., Toll Brothers Inc., UAL Corp., UnionBanCal Corp., Wendy's International Inc., MEMC Electronic Materials Inc., Winn-Dixie Stores Inc.

• Onyx Pharmaceuticals Inc. Q2 2008 Earnings Call Transcript

  Question-and-Answer Session Operator Thank you. We will now begin the question-and-answer session. Operator Instructions Our first question comes from Jim. Please state your full name and the company you are from. James Birchenough - Lehman Hi. It is Jim Birchenough with Lehman. Tony Coles Hi, Jim. How are you?...

  Earnings calls 2008-08-05

  Tags: Onyx Pharmaceuticals Inc.

• Onyx Pharmaceuticals Inc. Q1 2008 Earnings Call Transcript

  Question-and-Answer SessionOperator Thank you. Operator Instructions Your first question comes from Jim Birchenough from Lehman Brothers. Please go ahead. Jim Birchenough - Lehman Brothers Yes, hi guys. Just wondering if you can break out for us particularly in the US, the distribution between renal cell and liver cancer sales?...

  Earnings calls 2008-05-06

  Tags: Onyx Pharmaceuticals Inc.

• Onyx Pharmaceuticals Inc., Q4 2007 Earnings Call Transcript

  Question-and-Answer Session Operator Operator Instructions The first question comes from Steven Harr from Morgan Stanley. Please go ahead. Steven Harr - Morgan Stanley Hi. A couple of questions. First-off, on the safety side in the squamous cell population from the failed trial: Can you give us an idea or...

  Earnings calls 2008-02-19

  Tags: Onyx Pharmaceuticals Inc.

• Biotech Battle Focusing on Onyx Pharmaceuticals, Inc., Vion Pharmaceuticals, Inc, and PainCare Holdings, Inc.

  Comments made in this release are those of Maybach Financial Group and any questions or comments should be directed to the contact information located at the bottom of this release. Maybach Financial Group is a syndicate of financial analysts, with a core group representing over 250 years of total...

  Research articles 2007-11-07

  Tags: Biotechnology, FINANCE, financial, investor, Nasdaq Stock Market Inc., Onyx Pharmaceuticals Inc., Paincare Holdings Inc.

• Onyx Pharmaceuticals Q3 2007 Earnings Call Transcript

  Question-and-Answer SessionOperator Yes, thank you. We will now begin the question-and-answer session. Operator Instructions We have Steve Harr from Morgan Stanley. Please state your question. Steve Harr - Morgan Stanley I want to get just a little better sense for what's driving some of the growth that you're seeing...

  Earnings calls 2007-11-06

  Tags: Onyx Pharmaceuticals Inc.

• STOCK ALERT Newsletter Reports Timely Alert on Onyx Pharmaceuticals, Inc.

  M2 PRESSWIRE-27 February 2007-StockHeadquarters.com: STOCK ALERT Newsletter Reports Timely Alert on Onyx Pharmaceuticals, Inc.C1994-2007 M2 COMMUNICATIONS LTD RDATE:27022007 StockHeadquarters.com, the "30 Day Free Trial, Just To Prove It" newsletter known for making stock alerts to its subscribers just days or...

  Research articles 2007-02-27

  Tags: FINANCE, Investment, MARKETING, Nasdaq Stock Market Inc., newsletter, Onyx Pharmaceuticals Inc., stock

• STOCK ALERT Newsletter Reports On Its Outstanding Alert in Onyx Pharmaceuticals, Inc.

  M2 PRESSWIRE-14 February 2007-StockHeadquarters.com: STOCK ALERT Newsletter Reports On Its Outstanding Alert in Onyx Pharmaceuticals, Inc.C1994-2007 M2 COMMUNICATIONS LTD RDATE:14022007 www.StockHeadquarters.com, the newsletter known for getting its subscribers in high-flying stocks before big surges in the stock price does it...

  Research articles 2007-02-14

  Tags: Crane Co., FINANCE, Investment, MARKETING, Nasdaq Stock Market Inc., newsletter, Onyx Pharmaceuticals Inc., stock

• ONYX Pharmaceuticals, Inc. Announces Initial Public Offering

  RICHMOND, Calif.--BUSINESS WIRE--May 8, 1996--ONYX Pharmaceuticals, Inc. announced today the initial public offering of 2,500,000 shares of Common Stock at a price of $12.00 per share, with an over allotment of an additional 375,000 shares.ONYX will be listed on the Nasdaq National Market system under the symbol of ONXX.Montgomery Securities...

  Research articles 1996-05-08

  Tags: Business Wire, FINANCE, Investment, IPO, Onyx Pharmaceuticals Inc., Onyx Software, Richmond

Additional Resources

• Zacks Bull and Bear of the Day Highlights: tw telecom, AutoNation, TDS, Iron Mountain and Onyx Pharmaceuticals

  CHICAGO -- Zacks Equity Research highlights tw telecom, Inc. (Nasdaq: TWTC) as the Bull of the Day and AutoNation, Inc. (Nasdaq: AN) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Telephone & Data Systems (NYSE: TDS), Iron Mountain, Inc. (NYSE: IRM) and Onyx Pharmaceuticals,...

  Articles 2008-11-10

• BTG licenses novel anticancer compound to Onyx Pharmaceuticals

  BTG to receive $13m upfront plus potential milestones of up to $307m and sales royalties LONDON -- BTG plc (LSE: BGC), the life sciences company, announces it has granted worldwide rights to Onyx Pharmaceuticals, Inc. to develop and commercialise BTG's novel anticancer compound, BGC 945. Under...

  Articles 2008-11-07

• Yahoo shares plunge on Microsoft's cold shoulder

  Yahoo Inc. fell as much as 17 percent in Nasdaq trading after Microsoft Corp. said it has no interest in acquiring the Sunnyvale Internet company. Yahoo Chief Executive Officer Jerry Yang said this week the Internet company is willing to sell, fueling investor speculation that Microsoft...

  Articles 2008-11-07

• Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results

  Nexavar Net Sales increase 73% over Third Quarter 2007 EMERYVILLE, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. today reported its financial results for the three and nine months ended September 30, 2008. Onyx reported net income of $12.2 million, or $0.21 per diluted share,...

  Articles 2008-11-06

• Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International

  BGC 945 Builds Upon a Proven Class of Drugs With Greater Tumor Selectivity EMERYVILLE, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. today announced that it has in-licensed a novel targeted oncology compound, BGC 945, from BTG International Limited based in the United Kingdom. Under...

  Articles 2008-11-06

• Onyx Pharmaceuticals to Present at the 2008 Credit Suisse Health Care Conference

  EMERYVILLE, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. today announced that it will present at the 2008 Credit Suisse Health Care Conference on Wednesday, November 12, at 10:00 a.m. Mountain Time (9:00 a.m. Pacific Time). Interested parties may access a live webcast of the presentation on...

  Articles 2008-11-05

• New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer

  - Subanalyses from the Phase 3 SHARP and Asia-Pacific trials to be presented at 59th Annual Meeting of the American Association for the Study of Liver Diseases - WAYNE, N.J. and EMERYVILLE, Calif., Oct. 31 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. today...

  Articles 2008-10-31